Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey

Fuminori Murase, Yoshihiro Nishida, Shunsuke Hamada, Tomohisa Sakai, Koki Shimizu, and Takafumi Ueda

Japanese Journal of Clinical Oncology. 17 September 2021

ダウンロード
デスモイドアンケート調査JMOGstudy.pdf
PDFファイル 478.1 KB

Symptomatic Venous Thromboembolism in Patients with Malignant Bone and Soft Tissue Tumors: A Prospective Multicenter Cohort Study

Shintaro Iwata, Akira Kawai, Takafumi Ueda, Takeshi Ishii, Japanese Musculoskeletal Oncology Group (JMOG) 

Ann Surg Oncol. 2020 Nov 9. [Epub ahead of print] 

JMOG025


Clinical Outcomes of Patients with Metastatic Solitary Fibrous Tumors: A Japanese Musculoskeletal Oncology Group (JMOG) Multiinstitutional Study

Hidetatsu Outani, Eisuke Kobayashi, Junji Wasa, Masato Saito, Satoshi Takenaka, Keiko Hayakawa, Makoto Endo, Akihiko Takeuchi, Hiroshi Kobayashi, Munehisa Kito, Takeshi Morii, Jungo Imanishi, Takafumi Ueda 

Ann Surg Oncol. 2020 November 04. [Epub ahead of print] 

JMOG050

ダウンロード
JMOG050 2020-Annals_of_Surgical_Oncology
PDFファイル 455.7 KB

Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group

Nakamura T, Sugaya J, Naka N, Kobayashi H, Okuma T, Kunisada T, Asanuma K, Outani H, Nishimura S, Kawashima H, Akiyama T, Yasuda T, Miwa S, Sudo A, Ueda T 

Cancer Management and Research. 2020 October 12; 2020:12:10017-10022 

JMOG048

ダウンロード
cmar-270178-standard-treatment-remains-t
PDFファイル 950.4 KB

Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study

Hiroshi Urakawa, Akira Kawai, Takahiro Goto, Hiroaki Hiraga, Toshifumi Ozaki, Hiroyuki Tsuchiya, Robert Nakayama, Norifumi Naka, Yoshihiro Matsumoto, Eisuke Kobayashi, Tomotake Okuma, Toshiyuki Kunisada, Masahiko Ando, Takafumi Ueda, Yoshihiro Nishida 

Cancer Sci. 2020 Sep;111(9):3303-3312. 

JMOG038

ダウンロード
JMOG038コホート2.pdf
PDFファイル 702.8 KB

Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors

Yoshihiro Nishida, Hiroshi Urakawa, Robert Nakayama, Eisuke Kobayashi, Toshifumi Ozaki, Keisuke Ae, Yoshihiro Matsumoto, Hiroyuki Tsuchiya, Takahiro Goto, Hiroaki Hiraga, Norifumi Naka, Shunji Takahashi, Yuichi Ando, Masahiko Ando, Yachiyo Kuwatsuka, Shunsuke Hamada, Takafumi Ueda, Akira Kawai 

Int J Cancer. 2020 Jul 7. [Online ahead of print] 

JMOG038

ダウンロード
JMOG038コホート1.pdf
PDFファイル 665.6 KB

What Factors Are Associated With Treatment Outcomes of Japanese Patients With Clear Cell Chondrosarcoma?

Nakayama R, Hayakawa K, Kobayashi E, Endo M, Asano N, Yonemoto T, Kawashima H, Hamada K, Watanabe I, Futani H, Goto T, Nishida Y, Ozaki T. 

Clin Orthop Relat Res. 2020 Apr 14. [Epub ahead of print] 

JMOG040

ダウンロード
What_Factors_Are_Associated_with_Treatme
PDFファイル 450.6 KB

Efficacy and safety of trabectedin for patients with unresectable and relapsed soft‐tissue sarcoma in Japan: A Japanese Musculoskeletal Oncology Group study

Kobayashi H, Iwata S, Wakamatsu T, Hayakawa K, Yonemoto T, Wasa J, Oka H, Ueda T, Tanaka S. 

CANCER. 2019 Dec 11.[Epub ahead of print] 

JMOG043

ダウンロード
Kobayashi_et_al-2020-Cancer.pdf
PDFファイル 269.7 KB

The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

Heng M, Gupta A, Chung PW, Healey JH, Vaynrub M, Rose PS, Houdek MT, Lin PP, Bishop AJ, Hornicek FJ, Chen YL, Lozano-Calderon S, Holt GE, Han I, Biau D, Niu X, Bernthal NM, Ferguson PC, Wunder JS; Japanese Musculoskeletal Oncology Group (JMOG); Soft Tissue Osteosarcoma International Collaborative (STOIC). 

Eur J Cancer. 2020 Jan;125:130-141. 

JMOG035

ダウンロード
ESOS_EJC125Jan2020.pdf
PDFファイル 1.2 MB

Reconstruction using a constrained-type hip tumor prosthesis after resection of malignant periacetabular tumors: A study by the Japanese Musculoskeletal Oncology Group (JMOG).

Ogura K, Susa M, Morioka H, Matsumine A, Ishii T, Hamada K, Ueda T, Kawai A. 

J Surg Oncol. 2018;117(7):1455-1463. 

JMOG030


Mesenchymal chondrosarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients.

Tsuda Y, Ogura K, Hakozaki M, Kikuta K, Ae K, Tsuchiya H, Iwata S, Ueda T, Kawano H, Kawai A. 

J Surg Oncol. 2017 May;115(6):760-767. 

JMOG033

ダウンロード
Tsuda_et_al-2017-Journal_of_Surgical_Onc
PDFファイル 478.4 KB

Forty-eight cases of leiomyosarcoma of bone in Japan: A multicenter study from the Japanese musculoskeletal oncology group.

Mori T, Nakayama R, Endo M, Hiraga H, Tomita M, Fukase N, Kobayashi E, Kawai A, Ueda T, Morioka H.

J Surg Oncol. 2016;114:495-500. 

JMOG031

ダウンロード
Mori_et_al-2016-Journal_of_Surgical_Onco
PDFファイル 135.3 KB

Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study

Akihiko Takeuchi, Hiroyuki Tsuchiya, Takeshi Ishii, Yoshihiro Nishida, Satoshi Abe, Akihiko Matsumine, Akira Kawai, Kenichi Yoshimura and Takafumi Ueda 

BMC Musculoskeletal DisordersBMC series – open, inclusive and trusted. 2016;17:306(1-7). 

JMOG019


The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.

Nakamura T, Matsumine A, Kawai A, Araki N, Goto T, Yonemoto T, Sugiura H, Nishida Y, Hiraga H, Honoki K, Yasuda T, Boku S, Sudo A, Ueda T. 

CANCER. 2016 May 1;122(9):1408-16. Epub 2016 Mar 11. 

JMOG032


Atypical and malignant granular cell tumors in Japan: a Japanese Musculoskeletal Oncology Group (JMOG) study

Jungo Imanishi, Yasuo Yazawa, Tsuyoshi Saito, Michio Shimizu, Hiroyuki Kawashima, Keisuke Ae, Akihiko Matsumine, Tomoaki Torigoe, Hideshi Sugiura, Susumu Joyama. 

Int J Clin Oncol. 2016 Aug;21(4):808-16. 

JMOG026 

ダウンロード
MGCT_IJCO_2016.pdf
PDFファイル 1.1 MB

Factors that Influence Functional Outcome after Total or Subtotal Scapulectomy: Japanese Musculoskeletal Oncology Group (JMOG) Study.

Hayashi K, Iwata S, Ogose A, Kawai A, Ueda T, Otsuka T, Tsuchiya H. 

PLoS One. 2014 Jun 17;9(6):e100119. 

JMOG024


Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.

Yoneda Y, Kunisada T, Naka N, Kawai A, Morii T, Takeda K, Hasei J, Yamakawa, Ozaki T; Japanese Musculoskeletal Oncology Group.

Eur J Surg Oncol. 2014 Jan;40(1):49-54. 

JMOG016


Functional analysis of cases of tumor endoprostheses with deep infection around the knee: a multi institutional study by the Japanese Musculoskeletal Oncology Group (JMOG).

Morii T, Morioka H, Ueda T, Araki N, Hashimoto N, Kawai A, Takeuchi K, Anazawa U, Mochizuki K, Ichimura S.

J Orthop Sci 2013 Jul;18(4):605-12. Epub 2013 Apr 25 

JMOG022(2)


Deep infection in tumor endoprosthesis around the knee: a multi-institutional study by the Japanese musculoskeletal oncology group.

Morii T, Morioka H, Ueda T, Araki N, Hashimoto N, Kawai A, Mochizuki K, Ichimura S.

BMC Musculoskelet Disord 2013 Jan 31;14:51. 

JMOG022(1)


Clinical outcomes of Kyocera Modular Limb Salvage system after resection of bone sarcoma of the distal part of the femur: the Japanese Musculoskeletal Oncology Group study.

Nakamura T, Matsumine A, Uchida A, Kawai A, Nishida Y, Kunisada T, Araki N, Sugiura H, Tomita M, Yokouchi M, Ueda T, Sudo A.

Int Orthop.2014 Apr;38(4):825-30. 

JMOG020

ダウンロード
T_Nakamura_KMLS.pdf
PDFファイル 206.1 KB

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group.

Kawaguchi S, Tsukahara T, Ida K, Kimura S, Murase M, Kano M, Emori M, Nagoya S, Kaya M, Torigoe T, Ueda E, Takahashi A, Ishii T, Tatezaki S, Toguchida J, Tsuchiya H, Osanai T, Sugita T, Sugiura H, Ieguchi M, Ihara K, Hamada K, Kakizaki H, Morii T, Yasuda T, Tanizawa T, Ogose A, Yabe H, Yamashita T, Sato N, Wada T.

Cancer Sci. 2012;103(9):1625-1630. Epub 2012 Aug 7 

JMOG015


粘液型および脱分化型脂肪肉腫の治療成績

―年代別治療成績の検討を中心に―

穴澤卯圭、森岡秀夫、鈴木禎寿、森井建司、保坂聖一、浅野尚文、岩田慎太郎、尾崎敏文、柳川天志、川井章、西田佳弘、保坂泰介、上田孝文、矢部啓夫、骨軟部肉腫治療研究会、戸山芳昭

日整会誌 J.Jpn. Orthop. Assoc. 2012;86:647-653. 

JMOGa017


The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeltal Oncology Group.

Takeuchi A, Tsuchiya H, Niu X, Ueda T, Jeon DG, Wang EHM, Asavamongkolkul A, Kasuzaki K, Sakayama K, Kang YK The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeletal Oncology Group.

J Orthop Sci. 2011;16:196-202. 

JMOG019


Clinical outcomes of the KYOCERA Physio Hinge Total Knee System Type III after the resection of a bone and soft tissue tumor of the distal part of the femur.

Matsumine A, Ueda T, Sugita T, Yazawa Y, Isu K, Kawai A, Abe S, Yakushiji T, Hiraga H, Sudo A, Uchida A; Japanese Musculoskeletal Oncology Group.

J Surg Oncol. 2011;103(3):257-263. 

JMOG004


Osteosarcoma in the Elderly Over 60 Years: A Multicenter Study by the Japanese Musculoskeletal Oncology Group.

Nishida Y, Isu Y, Ueda T, Nishimoto Y, Tsuchiya H, Wada T, Sato K, Tsukushi S, Sugiura H.

Journal of Surgical Oncology. 2009;100:48-54. 

JMOG003


Current state of extendable prostheses for the lower limb in Japan. 

Yoshida Y, Iwata S, Ueda T, Kawai A, Isu K, Ryu J.

Surg Oncol. 2008;17:65-71. 

JMOG008


Extraskeletal osteosarcoma in Japan: multiinstitutional study of 20 patients from the Japanese Musculoskeletal Oncology Group.

Torigoe T, Yazawa Y, Takagi T, Terakado A, Kurosawa H.

J Orthop Sci. 2007;12:424-429. 

JMOG007


Clear Cell Sarcoma of tendons and Aponeuroses A Study of 75 Patients.

Kawai A, Hosono A, Nakayama R, Matsumine A, Matsumoto S, Ueda T, Tsuchiya H, Beppu Y, Morioka H, Yabe H, For the Japanese Musculoskeletal Oncology Group.

CANCER. 2007;109:109-16. 

JMOG018


Clinical Outcome of Patients With Ewing Sarcoma Family of Tumors of Bone in Japan The Japanese Musculoskeletal Oncology Group Cooperative Study.

Obata H, Ueda T, Kawai A, Ishida T, Ozaki T, Abe S, Tanaka K, Tsuchiya H, Matsumine A, Yabe H.

CANCER. 2007;109:767-75. 

JMOG005


Long-term follow-up after limb salvage in skeletally immature children with a primary malignant tumor of the distal end of the femur.

Futani H, Minamizaki T, Nishimoto Y, Abe S, Yabe H, Ueda T.

J Bone Joint Surg(A). 2006;88:595-603. 

JMOGa016


Clinical outcomes of 54 pelvic osteosarcomas registered by Japanese musculoskeletal oncology group.

Matsuo T, Sugita T, Sato K, Hotta T, Tsuchiya H, Shimose S, Kubo T, Ochi M.

Oncology. 2005;68(4-6): 375-81. Epub 2005 Jul 12 

JMOGa015


Alternating sequential chemotherapy with high-dose ifosfamide and doxorubicin/cyclophosphamide for adult non-small round cell soft tissue sarcoma.

Kawai A, Umeda T, Wada T, Ihara K, Isu K, Abe S, Ishii T, Sugiura, H, Araki N, Ozaki T, Yabe H, Hasegawa T, Tsugane S, Beppu Y.

J Orthop Sci. 2005;10:258-263. 

JMOG001


Alveolar soft part sarcoma in Japan: Multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group.

Ogose A, Yazawa Y, Ueda T, Hotta T, Kawashima H, Hatano H, Morita T.

Oncololgy. 2003;65:7-13.

JMOGa014


Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study.

Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, Asada N, Abe S, Isu K, Sugita T, Tomita K.

J Clin Oncol. 2002;20:3470-3477.

JMOGa013


Preoperative cisplatin for initial treatment of limb osteosarcoma: its local effect and impact on prognosis.

Abe S, Nishimoto Y, Isu K, Ishii T, Goto T.

Cancer Chemotherapy and Pharmacology. 2002;50:320-324.

JMOGa012


The management of pelvic chondrosarcoma in Japan.

Japanese Musculo-Skeletal Oncology Group.

Mochizuki K. Yamaguchi H. Umeda T.

International Orthopaedics(SICOT). 2000;24:65-70.

JMOGa011


Analysis of prognostic factors and hemotherapy of malignant fibrous histiocytoma of soft tissur: A preliminary report

Inter-group study.

Shinjo K.

Japanese Journal of Clinical Oncology. 1994;24:154-159.

JMOGa010


Prognosis of osteosarcoma treated by limb salvage surgery:The ten-year intergroup study in Japan.

Tsuchiya H, Tomita K.

Jpn J Clin Oncol. 1992;22:347-353.

JMOGa009


Intermediate results and functional evaluation of limb-salvage surgery for osteosarcoma: An intergroup study in Japan.

Tomita K, Tsuchiya H.

J Surg Oncol. 1989;41:71-76.

JMOGa008


Overall results and functional evaluation of limb salvage for ostesarcoma

Assessment and proposed reorganaization of functional evaluation system

New Developments for Limb Salvage in Musculoskeletal Tumors.

Tomita K., Aotake Y., Sugihara M., Tsuchiya H.

Springer-Verlage Tokyo. 1989:53-57.

JMOGa007


The effects of preoperative Cis-Platinum(CDDP) therapy for the purpose of limb salvage of osteosarcoma evaluated by multifactor evaluation method

Japanese Intergroup Study of Osteosarcoma

New Developments for Limb Salvage in Musculoskeletal Tumors.

Tateishi A, Miki H, Takeyama S, Ishii S, Yamawaki S, Yagi T, Kakizaki H, Chigira M, Takada N, Endo F, Kawano H, Osaka S, Higaki S, Hamada Y, Takeuchi S, Tomita K, Matsui H, Shinjo K, Daisaku H, Inoue O.

Springer-Verlage Tokyo. 1989:189-192.

JMOGa006


骨肉腫に対するシスプラチンの効果について

骨肉腫共同治験班

福間久俊、別府保男、中馬広一、八木知徳、山脇慎也、井須和男、船山完一、田沼正司、阿部義宏、鳥山貞宜、川野壽、板垣昌樹、富沢義宏、佐藤栄作、古屋光太郎、和田成仁、磯辺靖、川口智義、網野勝久、松本誠一、真鍋淳、杉浦勲、武内章二、葛西千秋、西本裕、櫛田喜輝、荻原義郎、鈴木勝美、須藤啓広、舘靖彦、内田淳正、吉川秀樹、林秀紀、青木康彰、濱田秀樹、石田俊武、大向孝良、前山巌、古瀬清夫、森本兼人、折戸隆、増田祥男、牛島正博、篠原典夫

癌と化学療法. 1989;16:811-817.

JMOGa005


骨肉腫患肢温存の動向

富田勝郎、土屋弘行、横川明男、立石昭夫、高田典彦、八木知徳、石井清一、山脇慎也、柿崎 寛、千木良正機、檜垣昇三、川野 寿、大幸俊三、井上幸雄、福島 博、舘崎慎一郎、新城 清、武内章二、内田淳正、林 英紀、遠藤寿男、葉 山泉、井上 治

臨整外. 1987;22:1147-1153. 

JMOGa004


骨・軟部悪性腫瘍症例に対するAdriamycinとCoenzyme Q10併用投与による副作用軽減効果について 

―その2:心電図変化について-

吉田豊、立石昭夫、山脇慎也、高田典彦、竹山信成、福島博、伊藤惣一郎、富田勝郎、館崎慎一郎、武内章二、藤内守

整形・災害外科. 1987;30:723-729.

JMOGa003


骨・軟部悪性腫瘍症例に対するAdriamycinとCoenzyme Q10併用投与による副作用軽減効果について 

―その1:骨髄機能障害、肝機能障害、消化器障害、脱毛などについて-

立石昭夫、山脇慎也、吉田豊、高田典彦、竹山信成、福島博、伊藤惣一郎、富田勝郎、館崎慎一郎、武内章二、藤内守

整形・災害外科. 1987;30:615-623.

JMOGa002


悪性腫瘍による骨破壊に伴う疼痛に対するブタ・カルシトニン(カルシタール)の効果

柄川順、川田祥裕、阿部光俊、三木浩、藤沼彰、宇都宮幸典、川野壽、川口裕充、黒岩茂夫、斉藤明義、宮渕龍雄、金田浩一、杉山丈夫

癌の臨床. 1984;30:251-258.

JMOGa001